The role of Tadalafil in the treatment of benign prostatic hyperplasia and erectile dysfunction

The aim of this study is to investigate the effectiveness a single 5 mg daily dose Tadalafil in patients with lower urinary tract symptoms (LUTS) due benign prostatic hyperplasia (BPH) accompanied by erectile dysfunction (ED). data who applied urology outpatient clinic between 2014 and 2019 were diagnosed BPH ED retrospectively analysed. Before after treatment tadalafil for 12 weeks; maximum flow rate (Qmax), average (Qave), postvoid residual volume (PVR), prostate (PV), PSA values, IPSS IIEF scores compared. mean age 66 male was 48.1±6.9 years. score before 9.85 which represents moderate LUTS. After treatment, decreased 5.7 mild showed 18.79. increased 29,9. statistically significantly (p=0.000). While Qmax Qave A significant decrease observed PVR from 60.1 ml 37.6 PV not (p=0.321). values found be p=0.046. It has been shown that use alone weeks can preferable option, especially younger / LUTS ED.